new_0222_0279|AKRO|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0279|AKRO|1|Akero Therapeutics Inc Total Current Assets (Quarterly) (USD)|Akero Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Akero Therapeutics Inc Inventories (Quarterly) (USD)|Akero Therapeutics Inc Net PP&E (Quarterly) (USD)|Akero Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Akero Therapeutics Inc Total Liabilities (Quarterly) (USD)|Akero Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Akero Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Akero Therapeutics Inc Total Deposits (Quarterly) (USD)|Akero Therapeutics Inc Book Value (Quarterly) (USD)|Akero Therapeutics Inc Retained Earnings (Quarterly) (USD)|Akero Therapeutics Inc Treasury Stock (Quarterly) (USD)|Akero Therapeutics Inc EV to Revenues|Akero Therapeutics Inc EV to Earnings|Akero Therapeutics Inc EV to Free Cash Flow|Akero Therapeutics Inc EV to Assets (Quarterly)|Akero Therapeutics Inc PS Ratio|Akero Therapeutics Inc PE Ratio|Akero Therapeutics Inc Price to Book Value|Akero Therapeutics Inc PEG Ratio|Akero Therapeutics Inc Debt to Equity Ratio|Akero Therapeutics Inc Dividend Yield|Akero Therapeutics Inc Shareholder Yield (TTM)|Akero Therapeutics Inc Percent of Shares Outstanding Short|Akero Therapeutics Inc Total Receivables (Quarterly) (USD)|Akero Therapeutics Inc Total Payables (Quarterly) (USD)|Akero Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Akero Therapeutics Inc Return on Invested Capital|Akero Therapeutics Inc Quality Ratio Score|Akero Therapeutics Inc Momentum Score|Akero Therapeutics Inc Beta (1Y)|Akero Therapeutics Inc Sustainable Growth Rate (TTM)|Akero Therapeutics Inc Institutional Investor Ownership Percentage|Akero Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Akero Therapeutics Inc Total Employees (Annual)|Akero Therapeutics Inc EPS Diluted (Quarterly) (USD)|Akero Therapeutics Inc Shares Outstanding|Akero Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Akero Therapeutics Inc Ordinary Shares Number (Quarterly)|Akero Therapeutics Inc Payout Ratio|Akero Therapeutics Inc Quick Ratio (Quarterly)|Akero Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Akero Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Akero Therapeutics Inc Effective Tax Rate (TTM)|Akero Therapeutics Inc Return on Equity|Akero Therapeutics Inc Net Income (TTM) (USD)|Akero Therapeutics Inc Revenue (TTM) (USD)|Akero Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Akero Therapeutics Inc Revenue (Quarterly) (USD)|Akero Therapeutics Inc Gross Profit (Quarterly) (USD)|Akero Therapeutics Inc SG&A Expense (Quarterly) (USD)|Akero Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Akero Therapeutics Inc Net Income (Quarterly) (USD)|Akero Therapeutics Inc Net Interest Income (Quarterly) (USD)|Akero Therapeutics Inc Price (USD)|Akero Therapeutics Inc Total Return Price (USD)|Akero Therapeutics Inc Enterprise Value (USD)|Akero Therapeutics Inc 30-Day Average Daily Volume|Akero Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0279|AKRO|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0279|AKRO|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0279|AKRO|5|91.2727272727|91.2727272727|0|91.2857142857|0|91.2727272727|91.2727272727|91.2727272727|0|91.2727272727|91.2727272727|0|0|0|6.95683453237|0|0|0|6.95683453237|0|0|1.44760479042|0|15.2903225806|0|91.2727272727|91.2727272727|0|0|32.2941176471|30.5263157895|0|0|91.3571428571|100.4|91.3571428571|36.7916666667|0|91.2727272727|0|0|91.3571428571|91.3846153846|0|0|91.2727272727|0|0|0|0|91.3571428571|91.3571428571|91.3571428571|91.5|6.95683453237|6.95683453237|6.95683453237|6.95488721805|1.44337349398||
new_0222_0279|AKRO|6|11|11|0|7|0|11|11|11|0|11|11|0|0|0|139|0|0|0|139|0|0|668|0|62|0|11|11|0|0|17|19|0|0|14|10|14|24|0|11|0|0|14|13|0|0|11|0|0|0|0|14|14|14|2|139|139|139|133|415||
new_0222_0279|AKRO|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0279|AKRO|201803||||||||||||||||||||||||||||||||||21.2242||-0.0198||||||-0.0198|||||||||0.195|-0.421|-0.421||||||||
new_0222_0279|AKRO|201806||||||||||||||||||||||||||||||||||21.2242||-0.4119||||||-0.4086|0||||||||0.242|-8.673|-8.673||||||||
new_0222_0279|AKRO|201809||||||||||||||||||||||||||||||||||21.2242||-0.5371||||||-0.5252|0||||||||0.474|-11.148|-11.148||||||||
new_0222_0279|AKRO|201812|77.131|75.975||||127.07|2.342|124.728||-49.919|-86.565|||||||||||||||1.373|0|||||||21.2242|10|-2.9057|||26.2951|||-2.8963|0|||-81.714|||||0.985|-61.472|-61.472||||||||
new_0222_0279|AKRO|201903|70.699|69.796||||2.404|2.404|0||69.662|-91.927|||||||||||||||0.952|0.002|||||||26.2951||-0.2039|||26.2951|||-0.2039||||-86.655|||||1.449|-5.362|-5.362|0.166|||||||
new_0222_0279|AKRO|201906|163.108|162.654||||4.779|4.74|0.039||158.389|-99.155||||-29.3368||||7.2056|||0||0.1952||3.248|0.003|||||||3.2684|10|-2.21|28.5554||28.5554|||-2.21|-97.08|||-85.21|||||1.649|-7.228|-7.228|0.381|18.56|18.56|432.1611|85686.8333||26.12|27.71
new_0222_0279|AKRO|201909|150.073|147.835||||6.759|6.725|0.034||143.384|-114.709||||-25.974||||3.5751|||0||1.7624||0.093|0.003|||||||28.0248|10|-0.56|28.5587||28.5587|||-0.56|1.628|||-89.616|||||2.424|-15.554|-15.554|0.755|19.83|19.83|403.5996|134419.5333||20.99|19.69
new_0222_0279|AKRO|201912|138.049|136.4||0||9.392|9.369|0.023||128.726|-130.32||||-19.0444||||4.597|||0||2.3448||0.947|0.003|||||||28.5678|14|-0.55|28.5678||28.5678|||-0.55|0|||-43.755|||||3.083|-15.611|-15.611||23.08|23.08|511.2998|133689.6667||24.69|21.77
new_0222_0279|AKRO|202003|126.218|125.285||0.226||8.298|8.286|0.012||118.323|-142.206||||-9.79||||3.7181|||0||2.8556||1.535|0.003|||||||28.4995|14|-0.42|28.6712||28.6712|||-0.42||||-50.279|||||3.588|-11.886|-11.886||16.73|16.73|342.2102|239636.8||21.5|24.93
new_0222_0279|AKRO|202006|113.193|102.833||||10.395|10.393|0.002||103.663|-158.413||||-14.4063||||5.942|||0||3.9039||2.536|0.003|||9|0.3033|||28.603|13|-0.57|28.6837||28.6837|||-0.57||||-59.258|||||3.417|-16.207|-16.207||24.52|24.52|577.7917|230644.5333|30.1305|36.12|31.65
new_0222_0279|AKRO|202009|298.033|291.87||1.847||13.578|12.014|1.564||286.458|-179.816||||-17.2356||||10.501|||0||3.9085||4.636|0.004|||7|0.6269|||34.0028|17|-0.63|34.7207||34.7207|||-0.63|-202.554|||-65.107|||||4.159|-21.403|-21.403||32.15|32.15|985.7311|162215.5|35.3407|26.5|29.23
new_0222_0279|AKRO|202012|271.345|268.387||1.793||14.627|13.111|1.516||258.712|-209.527||||-10.102||||3.0448|||0||7.2844||3.428|0.004|||8|0.7065|||34.708|21|-0.86|34.7416||34.7416|||-0.86|0|||-79.207|||||4.074|-29.711|-29.711||25.63|25.63|580.3416|223375.2333|16.2424|30.01|30.27
new_0222_0279|AKRO|202103|255.776|249.984||1.732||11.603|10.136|1.467||246.02|-224.617||||-10.1349||||3.8169|||0||8.2557||4.605|0.004|||6|0.5688|||34.7443|21|-0.43|34.7703||34.7703|||-0.43||||-82.411|||||4.526|-15.09|-15.09||28.4|28.4|719.0895|277597.1|36.8396|30.73|25.73
new_0222_0279|AKRO|202106|236.222|230.028||1.672||17.876|16.459|1.417||220.133|-253.55||||-8.2473||||3.6253|||0||9.8688||2.307|0.004|||3|1.2305|||34.8146|28|-0.83|34.8408||34.8408|||-0.83||||-95.137|||||4.99|-28.933|-28.933||25.61|25.61|641.9124|269973.3|-0.4414|21.4|23.74
new_0222_0279|AKRO|202109|221.807|215.081||1.612||24.905|23.54|1.365||198.628|-277.88||||-7.6231||||3.652|||0||7.9869||6.784|0.004|||2|0.9009|||34.8621|32|-0.7|34.8753||34.8753|||-0.7|0|||-98.064|||||4.883|-24.33|-24.33||23.06|23.06|573.8874|176796.1333|-27.4115|21.56|21.26
new_0222_0279|AKRO|202112|||||||||||||||-6.863||||3.7219|||0||10.8789||||||3|0.1588||||||||||||||||||||||||21.19|21.19|524.2021|221096.4|-18.0233|19.64|18.51